Study: Omicron evades some but not all monoclonal antibodies

Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.

Why omicron is more infectious than other coronavirus variants

The coronavirus will likely evade Paxlovid eventually. What that will mean for the pandemic is unclear

New Omicron subvariant BQ.1.1 resistant to al

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6

Antibodies, Free Full-Text

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern - eBioMedicine

Researchers unravel omicron's secrets to better understand COVID-19 – Washington University School of Medicine in St. Louis

Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization

COVID-19 – Omicron: resistant to most monoclo